Evidence map›Paper›PMID 40530441›Full record

ArticleArtificial organs2025

Ghost Cells as a Two-Phase Blood Analog Fluid-Optical Thrombus Growth Detection Using Particle Image Velocimetry.

Benjamin J Schürmann, Pia Creutz, Thomas Schmitz-Rode, Ulrich Steinseifer, Johanna C Clauser

Abstract read
In one paragraph

Article in Artificial organs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Benjamin J SchürmannDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, University Hospital RWTH Aachen University, Aachen, Germany.ORCID https://orcid.org/0009-0001-3007-3521
Pia CreutzDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, University Hospital RWTH Aachen University, Aachen, Germany.ORCID https://orcid.org/0009-0004-8428-1854
Thomas Schmitz-RodeInstitute of Applied Medical Engineering, University Hospital RWTH Aachen University, Aachen, Germany.ORCID https://orcid.org/0000-0002-1181-2165
Ulrich SteinseiferDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, University Hospital RWTH Aachen University, Aachen, Germany.ORCID https://orcid.org/0000-0002-8065-9803
Johanna C ClauserDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, University Hospital RWTH Aachen University, Aachen, Germany.ORCID https://orcid.org/0000-0002-9050-2391

Funding

Deutsche ForschungsgemeinschaftSTART-Program of the Faculty of Medicine RWTH Aachen University
6 · The paper itself

Abstract

backgroundIn vitro thrombosis tests for mechanical circulatory support systems lack standardized ISO guidelines. A major limitation of current approaches is the absence of continuous thrombus monitoring, as terminated experiments at a single time point fail to capture the dynamic nature of thrombus formation. However, spatially resolved thrombus formation and its underlying dynamics are crucial for the optimization of mechanical circulatory support systems.

methodsIn this study, we present a high-resolution thrombus monitoring approach using particle image velocimetry with a thrombogenic, two-phase blood analog fluid, designated as "ghost blood". Ghost blood consists of plasma and ghost cells, which are hemoglobin-depleted erythrocytes. We validate and quantify the particle image velocimetry with ghost blood and use this combination to monitor thrombus growth.

resultsThe validation demonstrated velocity fields in the FDA-pump are consistent with existing literature, confirming the usability of ghost blood in particle image velocimetry. The use range of ghost blood is quantified as a formula to determine the maximum possible optical penetration depth. Finally, thrombus growth was successfully monitored in the FDA-pump.

conclusionIn this proof of principle study, we grew a thrombus in the FDA-pump and were able to monitor its growth from a first thrombus thread to a complete obstruction of the flow. This approach enables both the localization and the temporal growth of the thrombus to be visualized and thereby provides a foundation for future advancements in thrombosis assessment and the optimization of mechanical circulatory support systems.

Indexed as

ErythrocytesHeart-Assist DevicesRheologyThrombosisHumansparticle image velocimetryresealed ghost cellsthrombus growth monitoringtranslucent two‐phase blood analog fluid

Identifiers

PMID40530441
PMCPMC13020648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.